Science Explorer Back to mapMap
Discussion
Company · Trenton · United States

Ono Pharmaceutical (United States)

In research, Ono Pharmaceutical (United States) stands highest in Medicine (#7,357 of 8,541 worldwide) and Health Sciences (#8,923 of 9,902 worldwide), 2022-now.

World rank, 2022-now
#21,297
of 22,385 · #11,660 all time
Rank in United States
#3,149
of 3,332
Research works
1.3k
▼ 12% vs 2018-21
Citations
41k
31.4 per fractional work
Top-10% rate
13.9%
all institutions 10.0%
vs its own fields
0.98×
1.00× is exactly expected
Open access
26%
world 40%
International
26%
world 18%

What is Ono Pharmaceutical (United States) known for in research?

The fields where it stands highest, 2022-now, ranked among every institution above the floor in each field.

FieldWorld rankWhere that sitsTop-10% rateWorksAll time
MedicineField #7,357 of 8,541 14.9%61 #8657
Health SciencesDomain #8,923 of 9,902 14.5%63 #10054

Each strip is that field's whole ranked pool, with the notch where Ono Pharmaceutical (United States) sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no average mark, because the average differs by field (from about 6% in Dentistry to 21% in Economics).

Which fields of science does Ono Pharmaceutical (United States) work in?

In 2022-now, 57% of research at Ono Pharmaceutical (United States) is in Health Sciences, 24% in Life Sciences. Its largest fields are Medicine (55%), Biochemistry, Genetics and Molecular Biology (14%), Immunology and Microbiology (5%). It does 2.3× the world's share of Health Sciences.

Health Sciences: 68 fractional works · 57.0% of its workMedicine: 66 fractional works · 55.2% of its workOncology: 15 fractional works · 12.7% of its workSurgery: 8 fractional works · 6.7% of its workPulmonary and Respiratory Medicine: 8 fractional works · 6.5% of its workRadiology, Nuclear Medicine and Imaging: 5 fractional works · 3.9% of its workPublic Health, Environmental and Occupational Health: 4 fractional works · 3.5% of its workEpidemiology: 4 fractional works · 3.5% of its workPathology and Forensic Medicine: 3 fractional works · 2.6% of its workRheumatology: 3 fractional works · 2.3% of its workPhysiology: 2 fractional works · 1.6% of its workPediatrics, Perinatology and Child Health: 2 fractional works · 1.5% of its workPharmacology: 2 fractional works · 1.3% of its workGenetics: 2 fractional works · 1.3% of its workInfectious Diseases: 1 fractional works · 1.1% of its workHematology: 1 fractional works · 0.9% of its workReproductive Medicine: 1 fractional works · 0.9% of its workEmergency Medicine: 1 fractional works · 0.7% of its workOtorhinolaryngology: 1 fractional works · 0.7% of its workNeurology: 1 fractional works · 0.6% of its workHepatology: 1 fractional works · 0.4% of its workComplementary and alternative medicine: 0 fractional works · 0.3% of its workHealth Informatics: 0 fractional works · 0.3% of its workGeriatrics and Gerontology: 0 fractional works · 0.3% of its workEndocrinology, Diabetes and Metabolism: 0 fractional works · 0.2% of its workFamily Practice: 0 fractional works · 0.2% of its workPsychiatry and Mental health: 0 fractional works · 0.2% of its workSmaller subfields together: 1 fractional works · 1.0% of its workHealth Professions: 2 fractional works · 1.6% of its workGeneral Health Professions: 1 fractional works · 1.0% of its workHealth Information Management: 1 fractional works · 0.5% of its workSmaller subfields together: 0 fractional works · 0.1% of its workNursing: 0 fractional works · 0.1% of its workVeterinary: 0 fractional works · 0.0% of its workLife Sciences: 29 fractional works · 24.3% of its workBiochemistry, Genetics and Molecular Biology: 17 fractional works · 14.4% of its workMolecular Biology: 12 fractional works · 10.0% of its workCancer Research: 3 fractional works · 2.7% of its workBiotechnology: 1 fractional works · 0.5% of its workPhysiology: 0 fractional works · 0.4% of its workCell Biology: 0 fractional works · 0.4% of its workGenetics: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.2% of its workImmunology and Microbiology: 6 fractional works · 4.9% of its workImmunology: 5 fractional works · 4.6% of its workApplied Microbiology and Biotechnology: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.0% of its workPharmacology, Toxicology and Pharmaceutics: 4 fractional works · 3.5% of its workPharmaceutical Science: 2 fractional works · 1.9% of its workPharmacology: 2 fractional works · 1.5% of its workNeuroscience: 1 fractional works · 0.8% of its workCellular and Molecular Neuroscience: 0 fractional works · 0.3% of its workSmaller subfields together: 1 fractional works · 0.5% of its workAgricultural and Biological Sciences: 1 fractional works · 0.7% of its workEcology, Evolution, Behavior and Systematics: 0 fractional works · 0.3% of its workPlant Science: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.2% of its workPhysical Sciences: 14 fractional works · 11.7% of its workChemistry: 5 fractional works · 4.3% of its workOrganic Chemistry: 4 fractional works · 3.2% of its workAnalytical Chemistry: 1 fractional works · 0.6% of its workSpectroscopy: 1 fractional works · 0.5% of its workSmaller subfields together: 0 fractional works · 0.1% of its workEngineering: 3 fractional works · 2.3% of its workBiomedical Engineering: 2 fractional works · 1.3% of its workComputational Mechanics: 1 fractional works · 0.5% of its workAerospace Engineering: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.2% of its workMathematics: 2 fractional works · 1.9% of its workStatistics and Probability: 2 fractional works · 1.8% of its workSmaller subfields together: 0 fractional works · 0.1% of its workComputer Science: 2 fractional works · 1.9% of its workComputational Theory and Mathematics: 1 fractional works · 1.2% of its workArtificial Intelligence: 1 fractional works · 0.7% of its workMaterials Science: 1 fractional works · 1.2% of its workMaterials Chemistry: 1 fractional works · 1.0% of its workSmaller subfields together: 0 fractional works · 0.1% of its workEnvironmental Science: 0 fractional works · 0.1% of its workPhysics and Astronomy: 0 fractional works · 0.1% of its workSocial Sciences: 8 fractional works · 7.0% of its workEconomics, Econometrics and Finance: 5 fractional works · 4.2% of its workEconomics and Econometrics: 5 fractional works · 4.2% of its workSocial Sciences: 2 fractional works · 1.4% of its workHealth: 1 fractional works · 0.9% of its workSociology and Political Science: 0 fractional works · 0.4% of its workSmaller subfields together: 0 fractional works · 0.1% of its workDecision Sciences: 1 fractional works · 0.6% of its workStatistics, Probability and Uncertainty: 0 fractional works · 0.3% of its workManagement Science and Operations Research: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.0% of its workPsychology: 1 fractional works · 0.5% of its workClinical Psychology: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.2% of its workArts and Humanities: 0 fractional works · 0.2% of its workGeneral Arts and Humanities: 0 fractional works · 0.2% of its workBusiness, Management and Accounting: 0 fractional works · 0.1% of its workALL ITS WORKOnoPharmaceutical…120fractional works, 2022-now
Life Sciences24%Physical Sciences12%Health Sciences57%Social Sciences7%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in 2022-now. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 22 fields, with their numbers
    1. Medicine6655.2%
    2. Health Professions21.6%
    3. Nursing00.1%
    4. Veterinary00.0%
    1. Biochemistry, Genetics and Molecular Biology1714.4%
    2. Immunology and Microbiology64.9%
    3. Pharmacology, Toxicology and Pharmaceutics43.5%
    4. Neuroscience10.8%
    5. Agricultural and Biological Sciences10.7%
    1. Chemistry54.3%
    2. Engineering32.3%
    3. Mathematics21.9%
    4. Computer Science21.9%
    5. Materials Science11.2%
    6. Environmental Science00.1%
    7. Physics and Astronomy00.1%
    1. Economics, Econometrics and Finance54.2%
    2. Social Sciences21.4%
    3. Decision Sciences10.6%
    4. Psychology10.5%
    5. Arts and Humanities00.2%
    6. Business, Management and Accounting00.1%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.15× its world share, 1 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 2.71× its world share, 17 worksBiochemistry, Geneti…Immunology and Microbiology: 4.85× its world share, 6 worksImmunology and Micro…Neuroscience: 0.47× its world share, 1 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 9.88× its world share, 4 worksPharmacology, Toxico…Chemistry: 2.76× its world share, 5 worksChemistryComputer Science: 0.24× its world share, 2 worksComputer ScienceEngineering: 0.15× its world share, 3 worksEngineeringEnvironmental Science: 0.02× its world share, 0 worksEnvironmental ScienceMaterials Science: 0.33× its world share, 1 worksMaterials ScienceMathematics: 1.61× its world share, 2 worksMathematicsPhysics and Astronomy: 0.03× its world share, 0 worksPhysics and AstronomyHealth Professions: 0.61× its world share, 2 worksHealth ProfessionsMedicine: 2.87× its world share, 66 worksMedicineNursing: 0.21× its world share, 0 worksNursingVeterinary: 0.29× its world share, 0 worksVeterinaryArts and Humanities: 0.07× its world share, 0 worksArts and HumanitiesBusiness, Management and Accounting: 0.03× its world share, 0 worksBusiness, Management…Decision Sciences: 0.59× its world share, 1 worksDecision SciencesEconomics, Econometrics and Finance: 1.97× its world share, 5 worksEconomics, Econometr…Psychology: 0.16× its world share, 1 worksPsychologySocial Sciences: 0.11× its world share, 2 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 9.9×. Every wedge is a field page.

All 22 fields, with their numbers
  1. Pharmacology, Toxicology and Pharmaceutics9.88×4 works
  2. Immunology and Microbiology4.85×6 works
  3. Medicine2.87×66 works
  4. Chemistry2.76×5 works
  5. Biochemistry, Genetics and Molecular Biology2.71×17 works
  6. Economics, Econometrics and Finance1.97×5 works
  7. Mathematics1.61×2 works
  8. Health Professions0.61×2 works
  9. Decision Sciences0.59×1 works
  10. Neuroscience0.47×1 works
  11. Materials Science0.33×1 works
  12. Veterinary0.29×0 works
  13. Computer Science0.24×2 works
  14. Nursing0.21×0 works
  15. Psychology0.16×1 works
  16. Agricultural and Biological Sciences0.15×1 works
  17. Engineering0.15×3 works
  18. Social Sciences0.11×2 works
  19. Arts and Humanities0.07×0 works
  20. Physics and Astronomy0.03×0 works
  21. Business, Management and Accounting0.03×0 works
  22. Environmental Science0.02×0 works

Who are the top researchers at Ono Pharmaceutical (United States)?

Ranked on the quality score, Steve Arkinstall, Stephen S. Palmer and Bo Marelli lead among researchers whose main affiliation is Ono Pharmaceutical (United States).

  1. 1 Steve Arkinstall United States · #986,031 worldwide 5k citations · 38 works
  2. 2 Stephen S. Palmer United States · #993,948 worldwide 2.5k citations · 83 works
  3. 3 Bo Marelli United States · #995,153 worldwide 963 citations · 45 works
  4. 4 Xuliang Jiang United States · #1,093,100 worldwide 2.4k citations · 60 works
  5. 5 David Fischer United States · #1,425,537 worldwide 2k citations · 45 works
  6. 6 Berend Neuteboom United States · #1,766,340 worldwide 1.1k citations · 20 works
  7. 7 Herbert L. Stone United States · #1,920,703 worldwide 2.9k citations · 21 works
  8. 8 Gabriela P. Saborı́o United States · #2,250,492 worldwide 2.6k citations · 16 works
  9. 9 Vanita D. Sood United States · #2,272,339 worldwide 740 citations · 25 works
  10. 10 Jean-Marie Cuillerot United States · #2,329,926 worldwide 2.1k citations · 42 works
All ranked researchers at Ono Pharmaceutical (United States)

What are the most cited papers from Ono Pharmaceutical (United States)?

The most cited paper from Ono Pharmaceutical (United States) is "Ferroptosis: A Regulated Cell Death Nexus Linking Metabolism, Redox Biology, and Disease" (Brent R. Stockwell et al., 2017), with 7,867 citations. Next come "Applications of machine learning in drug discovery and development" (3,274) and "Sensitive detection of pathological prion protein by cyclic amplification of protein misfolding" (1,317).

Most cited papers
#PaperReleasedCitations
1 Ferroptosis: A Regulated Cell Death Nexus Linking Metabolism, Redox Biology, and Disease Brent R. Stockwell et al. · Cell Open access Oct 2017 7,867
2 Applications of machine learning in drug discovery and development Jessica J. Vamathevan, Dominic A. Clark, Paul Czodrowski et al. · Nature Reviews Drug Discovery ReviewOpen access 11 Apr 2019 3,274
3 Sensitive detection of pathological prion protein by cyclic amplification of protein misfolding Gabriela P. Saborı́o, Bruno Permanne, Claudio A. Soto · Nature 14 Jun 2001 1,317
4 Avelumab in patients with chemotherapy-refractory metastatic Merkel cell carcinoma: a multicentre, single-group, open-label, phase 2 trial Howard L. Kaufman, Jeffery Scott Russell, Omid Hamid et al. · The Lancet Oncology Open access 7 Sep 2016 1,235
5 An empirical correlation of second virial coefficients Constantine Tsonopoulos · AIChE Journal Mar 1974 971
All 60 most cited papers, with filters and sorting

Which keywords describe research at Ono Pharmaceutical (United States)?

By fractional works in 2022-now, weighted toward what it does more of than the world: Chemotherapy, Immunotherapy, Molecular Characterization, Neoadjuvant Therapy, Clinical Trials, Targeted Therapy, Tumor Microenvironment and Guidelines.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in 2022-now in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Chemotherapy13▲ 15×15 topics
  2. Immunotherapy11▲ 12×13 topics
  3. Molecular Characterization8▲ 38×4 topics
  4. Neoadjuvant Therapy7▲ 25×5 topics
  5. Clinical Trials7▲ 8.7×9 topics
  6. Cancer7▲ 4.3×23 topics
  7. Targeted Therapy7▲ 25×4 topics
  8. Tumor Microenvironment6▲ 12×7 topics
  9. Inflammation6▲ 2.5×24 topics
  10. Guidelines6▲ 11×2 topics
  11. Bladder Cancer6▲ 132×1 topic
  12. Urothelial Carcinoma6▲ 114×1 topic
  13. Machine Learning6▲ 1.41×12 topics
  14. Prognostic Factors6▲ 11×7 topics
  15. Cancer Therapy5▲ 6.9×11 topics
  16. Quality of Life5▲ 2.6×9 topics
  17. Monoclonal Antibodies4▲ 41×3 topics
  18. Pharmacokinetics4▲ 11×6 topics
  19. Glycosylation4▲ 27×3 topics
  20. Therapeutic Antibodies4▲ 42×2 topics
  21. Immune Checkpoint Blockade3▲ 25×1 topic
  22. PD-1 and PD-L13▲ 25×1 topic
  23. Autoantibodies3▲ 12×7 topics
  24. Biomarkers3▲ 3.9×6 topics
  25. ALK Inhibitors3▲ 41×1 topic
  26. EGFR Mutations3▲ 41×1 topic
  27. Genomic Profiling3▲ 25×2 topics
  28. Medicinal Chemistry3▲ 9.6×4 topics
  29. Genomic Instability3▲ 22×3 topics
  30. Precision Medicine3▲ 5.1×4 topics
  31. Cell Death3▲ 9.9×5 topics
  32. Antibody Engineering3▲ 42×1 topic
  33. Fc Receptors3▲ 42×1 topic
  34. Metastasis3▲ 6.5×8 topics
  35. Cognitive Impairment2▲ 8.2×5 topics
  36. Homologous Recombination2▲ 44×2 topics
  37. Cancer Incidence2▲ 15×3 topics
  38. Cost-effectiveness Analysis2▲ 25×1 topic
  39. Health Utility Measures2▲ 25×1 topic
  40. Anticancer Agents2▲ 12×6 topics

Which research topics does Ono Pharmaceutical (United States) publish most on?

By volume in 2022-now: Bladder and Urothelial Cancer Treatments, Cancer Immunotherapy and Biomarkers, Lung Cancer Treatments and Mutations and Monoclonal and Polyclonal Antibodies Research.

  1. 1 Bladder and Urothelial Cancer Treatments Surgery 6 works
  2. 2 Cancer Immunotherapy and Biomarkers Oncology 3 works
  3. 3 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 3 works
  4. 4 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 3 works
  5. 5 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 2 works
  6. 6 Systemic Lupus Erythematosus Research Rheumatology 2 works
  7. 7 Economic and Financial Impacts of Cancer Economics and Econometrics 2 works
  8. 8 Multiple Sclerosis Research Studies Pathology and Forensic Medicine 2 works
  9. 9 Cancer Genomics and Diagnostics Cancer Research 2 works
  10. 10 Statistical Methods in Clinical Trials Statistics and Probability 2 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available26.3%not open73.7%

World: 40% of research is openly available.

with international co-authors26.0%domestic only74.0%

World: 18% is written across borders.

How has Ono Pharmaceutical (United States)'s research output changed?

Output in 2022-2025 was 12% lower than in 2018-2021.

still counting1990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Ono Pharmaceutical (United States) as a percentage of every work published that year, 0.00043% in 2024.

still counting0.010%0.020%0.030%Ono Pharmaceutical (United States)0.00031% in 202519801990200020102020

Fractional works of Ono Pharmaceutical (United States) over all fractional works that year. How the balance of science has shifted.

How much of it reaches the world top 10%

Year by year, against all institutions in the same year.

10%20%30%Ono Pharmaceutical (United States)26.0% in 2024all institutions10.0% in 202420102020

Of each year's output, the share that reached the world's 10% most cited for its field and year. Peak 26.0% in 2024.

Other research institutions in Trenton

All research institutions in Trenton

Share Ono Pharmaceutical (United States)'s ranking

Ono Pharmaceutical (United States) on Science Explorer

A card with Ono Pharmaceutical (United States)'s standing and the fields it leads in, for a post or a slide. A link to this page previews as the same card.

Download the card

1200 × 630 PNG, sized for social posts, drawn from the latest snapshot.

Badges for a website1Each links back here and updates with every snapshot

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Ono Pharmaceutical (United States). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.